• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用常规收集的真实世界健康数据确定乳腺癌无复发生存的新方法。

New method for determining breast cancer recurrence-free survival using routinely collected real-world health data.

机构信息

Department of Economics, Faculty of Arts, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada.

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3D10 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada.

出版信息

BMC Cancer. 2022 Mar 16;22(1):281. doi: 10.1186/s12885-022-09333-6.

DOI:10.1186/s12885-022-09333-6
PMID:35296284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8925135/
Abstract

BACKGROUND

In cancer survival analyses using population-based data, researchers face the challenge of ascertaining the timing of recurrence. We previously developed algorithms to identify recurrence of breast cancer. This is a follow-up study to detect the timing of recurrence.

METHODS

Health events that signified recurrence and timing were obtained from routinely collected administrative data. The timing of recurrence was estimated by finding the timing of key indicator events using three different algorithms, respectively. For validation, we compared algorithm-estimated timing of recurrence with that obtained from chart-reviewed data. We further compared the results of cox regressions models (modeling recurrence-free survival) based on the algorithms versus chart review.

RESULTS

In total, 598 breast cancer patients were included. 121 (20.2%) had recurrence after a median follow-up of 4 years. Based on the high accuracy algorithm for identifying the presence of recurrence (with 94.2% sensitivity and 79.2% positive predictive value), the majority (64.5%) of the algorithm-estimated recurrence dates fell within 3 months of the corresponding chart review determined recurrence dates. The algorithm estimated and chart-reviewed data generated Kaplan-Meier (K-M) curves and Cox regression results for recurrence-free survival (hazard ratios and P-values) were very similar.

CONCLUSION

The proposed algorithms for identifying the timing of breast cancer recurrence achieved similar results to the chart review data and were potentially useful in survival analysis.

摘要

背景

在使用基于人群的数据进行癌症生存分析时,研究人员面临确定复发时间的挑战。我们之前开发了用于识别乳腺癌复发的算法。这是一项后续研究,旨在检测复发的时间。

方法

使用常规收集的行政数据获取表示复发和时间的健康事件。通过使用三种不同的算法分别找到关键指标事件的时间来估计复发的时间。为了验证,我们将算法估计的复发时间与从图表审查数据中获得的时间进行了比较。我们进一步比较了基于算法和图表审查的 Cox 回归模型(无复发生存率模型)的结果。

结果

共纳入 598 例乳腺癌患者。中位随访 4 年后,有 121 例(20.2%)复发。基于用于识别复发存在的高准确性算法(灵敏度为 94.2%,阳性预测值为 79.2%),大多数(64.5%)算法估计的复发日期与相应图表审查确定的复发日期相差 3 个月以内。算法估计和图表审查数据生成了无复发生存率的 Kaplan-Meier(K-M)曲线和 Cox 回归结果(风险比和 P 值)非常相似。

结论

用于确定乳腺癌复发时间的建议算法与图表审查数据产生了相似的结果,并且在生存分析中可能有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1614/8925135/f088fad8cfc7/12885_2022_9333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1614/8925135/f088fad8cfc7/12885_2022_9333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1614/8925135/f088fad8cfc7/12885_2022_9333_Fig1_HTML.jpg

相似文献

1
New method for determining breast cancer recurrence-free survival using routinely collected real-world health data.利用常规收集的真实世界健康数据确定乳腺癌无复发生存的新方法。
BMC Cancer. 2022 Mar 16;22(1):281. doi: 10.1186/s12885-022-09333-6.
2
Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data.使用常规收集的行政数据开发和验证乳腺癌复发的病例发现算法。
BMC Cancer. 2019 Mar 8;19(1):210. doi: 10.1186/s12885-019-5432-8.
3
Validated algorithms for identifying timing of second event of oropharyngeal squamous cell carcinoma using real-world data.使用真实世界数据验证识别口咽鳞癌第二事件时间的算法。
Head Neck. 2022 Aug;44(8):1909-1917. doi: 10.1002/hed.27109. Epub 2022 Jun 2.
4
Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm.开发、验证和传播一种用于乳腺癌复发检测和时间信息学算法。
J Natl Cancer Inst. 2018 Mar 1;110(3):273-281. doi: 10.1093/jnci/djx200.
5
Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.通过选择性使用病历数据增强乳腺癌复发算法
J Natl Cancer Inst. 2015 Nov 18;108(3). doi: 10.1093/jnci/djv336. Print 2016 Mar.
6
An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events.一种基于电子健康记录的确定第二次乳腺癌事件日期的算法。
Med Care. 2017 Dec;55(12):e81-e87. doi: 10.1097/MLR.0000000000000352.
7
Evaluation of algorithms using administrative health and structured electronic medical record data to determine breast and colorectal cancer recurrence in a Canadian province : Using algorithms to determine breast and colorectal cancer recurrence.利用加拿大省级卫生行政和结构化电子病历数据评估算法以确定乳腺癌和结直肠癌的复发情况:利用算法确定乳腺癌和结直肠癌的复发情况。
BMC Cancer. 2021 Jul 1;21(1):763. doi: 10.1186/s12885-021-08526-9.
8
A validated algorithm for register-based identification of patients with recurrence of breast cancer-Based on Danish Breast Cancer Group (DBCG) data.基于丹麦乳腺癌群组(DBCG)数据的乳腺癌复发患者的登记处识别验证算法。
Cancer Epidemiol. 2019 Apr;59:129-134. doi: 10.1016/j.canep.2019.01.016. Epub 2019 Feb 8.
9
Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy.建立用于预测接受乳房切除术的T1至T2期淋巴结阴性乳腺癌患者局部区域复发的风险评分系统:对术后放疗的意义。
Medicine (Baltimore). 2017 Jun;96(26):e7343. doi: 10.1097/MD.0000000000007343.
10
A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive Recurrences.可能预示乳腺癌放射治疗后早期与晚期复发的特征,有助于了解早期侵袭性复发的生物学特征。
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):686-696. doi: 10.1016/j.ijrobp.2020.05.015. Epub 2020 May 17.

引用本文的文献

1
A population-based estimation of breast cancer recurrence in northeast Italy with administrative healthcare databases.利用行政医疗保健数据库对意大利东北部乳腺癌复发情况进行基于人群的估计。
Breast. 2025 May 1;82:104487. doi: 10.1016/j.breast.2025.104487.
2
Leveraging survival analysis and machine learning for accurate prediction of breast cancer recurrence and metastasis.利用生存分析和机器学习准确预测乳腺癌复发和转移。
Sci Rep. 2025 Jan 29;15(1):3728. doi: 10.1038/s41598-025-87622-3.
3
Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment data.

本文引用的文献

1
Incorporating Breast Cancer Recurrence Events Into Population-Based Cancer Registries Using Medical Claims: Cohort Study.利用医疗理赔数据将乳腺癌复发事件纳入基于人群的癌症登记系统:队列研究
JMIR Cancer. 2020 Aug 17;6(2):e18143. doi: 10.2196/18143.
2
Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data.使用常规收集的行政数据开发和验证乳腺癌复发的病例发现算法。
BMC Cancer. 2019 Mar 8;19(1):210. doi: 10.1186/s12885-019-5432-8.
3
A validated algorithm for register-based identification of patients with recurrence of breast cancer-Based on Danish Breast Cancer Group (DBCG) data.
澳大利亚新南威尔士州非转移性癌症对无事件生存期造成干扰的估计发病率——一项基于癌症登记与治疗数据关联的全人群流行病学研究。
Front Oncol. 2024 Aug 21;14:1338754. doi: 10.3389/fonc.2024.1338754. eCollection 2024.
4
Adjuvant Ovarian Function Suppression in Premenopausal Hormone Receptor-Positive Breast Cancer.绝经前激素受体阳性乳腺癌的辅助卵巢功能抑制。
JAMA Netw Open. 2024 Mar 4;7(3):e242082. doi: 10.1001/jamanetworkopen.2024.2082.
5
Racial Disparities in the Ascertainment of Cancer Recurrence in Electronic Health Records.电子健康记录中癌症复发的种族差异。
JCO Clin Cancer Inform. 2023 Jun;7:e2300004. doi: 10.1200/CCI.23.00004.
6
Direct-to-Implant Breast Reconstruction After Unilateral and Bilateral Mastectomy: Cross-Sectional Study of Patient Satisfaction and Quality of Life with BREAST-Q.单侧和双侧乳房切除术后直接植入式乳房重建:BREAST-Q对患者满意度和生活质量的横断面研究
Aesthetic Plast Surg. 2023 Feb;47(1):43-49. doi: 10.1007/s00266-022-02986-5. Epub 2022 Aug 4.
7
Bias and Class Imbalance in Oncologic Data-Towards Inclusive and Transferrable AI in Large Scale Oncology Data Sets.肿瘤学数据中的偏差与类别不平衡——迈向大规模肿瘤学数据集中的包容性和可转移人工智能
Cancers (Basel). 2022 Jun 12;14(12):2897. doi: 10.3390/cancers14122897.
基于丹麦乳腺癌群组(DBCG)数据的乳腺癌复发患者的登记处识别验证算法。
Cancer Epidemiol. 2019 Apr;59:129-134. doi: 10.1016/j.canep.2019.01.016. Epub 2019 Feb 8.
4
Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm.开发、验证和传播一种用于乳腺癌复发检测和时间信息学算法。
J Natl Cancer Inst. 2018 Mar 1;110(3):273-281. doi: 10.1093/jnci/djx200.
5
An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events.一种基于电子健康记录的确定第二次乳腺癌事件日期的算法。
Med Care. 2017 Dec;55(12):e81-e87. doi: 10.1097/MLR.0000000000000352.
6
Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.通过选择性使用病历数据增强乳腺癌复发算法
J Natl Cancer Inst. 2015 Nov 18;108(3). doi: 10.1093/jnci/djv336. Print 2016 Mar.
7
Neoadjuvant Chemotherapy for Breast Cancer, Is Practice Changing? A Population-Based Review of Current Surgical Trends.乳腺癌新辅助化疗:实践正在改变吗?基于人群的当前手术趋势回顾。
Ann Surg Oncol. 2015 Oct;22(10):3376-82. doi: 10.1245/s10434-015-4714-x. Epub 2015 Jul 23.
8
Challenges and opportunities in measuring cancer recurrence in the United States.美国癌症复发检测中的挑战与机遇。
J Natl Cancer Inst. 2015 May 12;107(8). doi: 10.1093/jnci/djv134. Print 2015 Aug.
9
A hybrid approach to identify subsequent breast cancer using pathology and automated health information data.一种使用病理学和自动化健康信息数据来识别后续乳腺癌的混合方法。
Med Care. 2015 Apr;53(4):380-5. doi: 10.1097/MLR.0000000000000327.
10
Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence.利用自然语言处理提高研究中手动图表提取的效率:以乳腺癌复发为例。
Am J Epidemiol. 2014 Mar 15;179(6):749-58. doi: 10.1093/aje/kwt441. Epub 2014 Jan 30.